友邦香港「2019冠狀病毒病」相關理賠總額累達3,700萬元
友邦香港宣布延續「免費疫苗副作用防護保障」措施至今年12月31日,而與「2019冠狀病毒病」相關的理賠總額至今達3,700萬元。
友邦香港繼續為所有合資格香港及澳門的個人客戶及團體保險客戶(及受保家屬),提供「免費疫苗副作用防護保障」,客戶無需登記,便可自動享有保障。
「免費疫苗副作用防護保障」包括最新2019冠肺炎疫苗、季節性流感疫苗、乙型肝炎疫苗等香港及澳門之認可疫苗。友邦香港早已預留總賠償額達1億港元或澳門元,用作該免費保障的住院前門診賠償(300港元或澳門元)、住院現金賠償(每日800港元或澳門元及最多14日)及若不幸離世的恩恤金(15萬港元或澳門元)。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of this article is for reference only. It does not constitute an offer, solicitation, recommendation, opinion or guarantee of any securities, financial products or instruments.The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance.